Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience. The com... Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Takhzyro, Advate, Elaprase, Replagal, Vpriv, Adynovate/Adynovi, Livtencity, ADZYNMA, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Flexbumin, Adcetris, Leuplin/Enantone, Ninlaro, Iclusig, FRUZAQLA, Alunbrig, vyvanse/elvanse, Trintellix, and QDENGA brands. It has licensing and collaboration for the development and commercialization of products with Arrowhead Pharmaceuticals, Cour Pharmaceuticals, Engitix, Halozyme, Mirum Pharmaceuticals, Ucsd/Fortis Advisors, Zedira/Dr. Falk Pharma, Ac Immune, Acurastem, Anima Biotech, Biomarin, Denali Therapeutics, Luxna Biotech, Neurocrine Biosciences, Peptidream, Abbvie, Adimab, Ascentage Pharma, Crescendo Biologics, Exelixis, F-Star, Gsk, Heidelberg Pharma, Innovent Biologics, Keros Therapeutics, Kumquat Biosciences, Protagonist Therapeutics, Halozyme, Kamada, Johnson & Johnson/Momenta Pharmaceuticals, Previpharma, Novavax, Bridgene Biosciences, Charles River Laboratories, Iambic Therapeutics, Ipsen, Km Biologics, Massachusetts Institute Of Technology, and Nabla Bio. The company operates in Japan, the United States. Europe, Canada, Latin America, China, Asia, Russia/Commonwealth of Independent States, the Middle East, Oceania, and Africa. The company was founded in 1781 and is headquartered in Chuo, Japan. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 1.425 | 4.66067048242 | 30.575 | 32 | 29.43 | 30515 | 29.4332241 | CS |
| 4 | 0.70005 | 2.23658504247 | 31.29995 | 34.28 | 29.33 | 34749 | 31.90535803 | CS |
| 12 | -4.24 | -11.6997792494 | 36.24 | 36.24 | 29.33 | 20168 | 32.44814393 | CS |
| 26 | 0.41 | 1.29787907566 | 31.59 | 39.2 | 29.33 | 73374 | 33.58904046 | CS |
| 52 | 2.68 | 9.14051841746 | 29.32 | 39.2 | 26.33 | 87185 | 30.55040379 | CS |
| 156 | 0.77 | 2.4655779699 | 31.23 | 39.2 | 23.8 | 50787 | 29.41949374 | CS |
| 260 | -1 | -3.0303030303 | 33 | 39.2 | 23.8 | 50863 | 29.65013455 | CS |
lmcl123
4分前
3331
4分前
Wrangler1
9分前
DiamondHealer95
17分前
JusDePomme
19分前
norisknorewards
21分前
satter
28分前
satter
35分前
MJAM2020
40分前
Jack_Bolander
49分前
Jack_Bolander
50分前
laraz5
52分前
uber darthium
53分前
LOB
53分前
TightCoil
55分前
MonkRebel181
60分前
gmac8625
1時間前
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。